Skip to main content

Advertisement

Log in

First Description of Parathyroid Disease in Multiple Endocrine Neoplasia 2A Syndrome

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Hyperparathyroidism and/or parathyroid hyperplasia, medullary thyroid carcinoma (MTC), and pheochromocytomas compose the hallmarks of the multiple endocrine neoplasia type 2A (MEN 2A) syndrome. Revisiting a report in 1939 of a patient with hyperparathyroidism and parathyroid hyperplasia led to a search for evidence of MEN 2A. From medical records and discussion with family members, longitudinal follow-up of the patient and her descendants was obtained. Molecular diagnostics were integrated in the care of subsequent generations. The literature on hyperparathyroidism and MEN 2A was reviewed. Children of the proband exhibited all components of MEN 2A and the RET mutation of 634 TGC>CGC. The pedigree was typical for this mutation. Papers on anthropologic studies demonstrate skeletal evidence of hyperparathyroidism in humans centuries ago. The initial report of the proband preceded the publications defining both MTC and MEN 2A. The values of in-depth family histories and genetic analyses are exemplified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Neumann HPH, Vortmeyer A, Schmidt D, et al. Evidence of MEN-2 in the original description of classic pheochromocytoma. New Eng J Med 357:1311–5, 2007. doi:10.1056/NEJMoa071407.

    Article  PubMed  CAS  Google Scholar 

  2. Barker VL, Brines OA. Hyperfunctioning adenoma of an ectopic parathyroid gland. Arch Surg 39:205–13, 1939.

    Google Scholar 

  3. Hazard JB, Hawk WA, Crile G Jr. Medullary (solid) carcinoma of the thyroid—a clinicopathologic entity. J Clin Endocrinol Metab 19:152–61, 1959.

    PubMed  CAS  Google Scholar 

  4. Sipple JH. The association of pheochormocytoma with carcinoma of the thyroid gland. Am J Med 31:163–6, 1961. doi:10.1016/0002-9343(61)90234-0.

    Article  Google Scholar 

  5. World Health Organization. Classification of tumours. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology genetics of tumours of endocrine organs. Lyon, France: IARC, p. 215, 2004.

    Google Scholar 

  6. Cushman P Jr. Familial endocrine tumors. Report of two unrelated kindred affected with pheochromocytomas, one also with multiple thyroid carcinomas. Am J Med 32:352–60, 1962. doi:10.1016/0002-9343(62)90126-2.

    Article  PubMed  Google Scholar 

  7. Manning PC Jr, Molnar GD, Black BM, et al. Pheochromocytoma, hyperparathyroidism and thyroid carcinoma occurring coincidentally. Report of a case. New Eng J Med 268:68–72, 1963.

    Article  Google Scholar 

  8. Yip L, Cote GJ, Shapiro SE, et al. Multiple endocrine neoplasia type 2. Evaluation of the genotype–phenotype relationship. Arch Surg 138:409–16, 2003. doi:10.1001/archsurg.138.4.409.

    Article  PubMed  CAS  Google Scholar 

  9. Modigliani E, Cohen R, Campos J-M, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol 48:265–73, 1998. doi:10.1046/j.1365-2265.1998.00392.x.

    Article  CAS  Google Scholar 

  10. Schuffenecker I, Virally-Monad M, Brohet R, et al. Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. J Clin Endocrinol Metab 83:487–91, 1998. doi:10.1210/jc.83.2.487.

    Article  PubMed  CAS  Google Scholar 

  11. Kraimps J-L, Denizot A, Carnaille B, et al. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. World J Surg 20:808–13, 1996. doi:10.1007/s002689900123.

    Article  PubMed  CAS  Google Scholar 

  12. Raue F, Kraimps JL, Dralle H, et al. Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238:369–73, 1995.

    Article  PubMed  CAS  Google Scholar 

  13. Jackson MB, Guttenberg M, Hedrick H, Moshang T Jr. Multiple endocrine neoplasia type 2A in a kindred with C634Y mutation. Pediatrics 116:e468–71, 2005. doi:10.1542/peds.2005-0033.

    Article  PubMed  Google Scholar 

  14. Askanazy M. Ueber ostitis deformans ohne osteoides gewebe. In: von Baumgarten P, ed. Arbeiten Pathologischen Anatomie und Bacteriologie. Leipzig, Germany: Verlag von S. Hirzel, pp. 398–422, 1904.

    Google Scholar 

  15. Mandl F. Therapeutischer versuch bei osteitis fibrosa generalisata mittels extirpation eines epithelkorperchentumors. Wien Klin Wchenschr 38:1343–4, 1925.

    Google Scholar 

  16. Mandl F. Hyperparathyroidism. Surgery 21:394–440, 1947.

    CAS  PubMed  Google Scholar 

  17. Barr DP, Bulger HA, Dixon HH. Hyperparathyroidism. JAMA 92:951–2, 1929.

    Google Scholar 

  18. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–71, 2001. doi:10.1210/jc.86.12.5658.

    Article  PubMed  CAS  Google Scholar 

  19. Mizusawa N, Uchino S, Iwata T, et al. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol 65:9–16, 2006. doi:10.1111/j.1365-2265.2006.02534.x.

    Article  CAS  Google Scholar 

  20. Goldman L, Smyth FS. Hyperparathyroidism in siblings. Ann Surg 104:971–81, 1936. doi:10.1097/00000658-193612000-00002.

    Article  PubMed  CAS  Google Scholar 

  21. Shirahama S, Ogura K, Takami H, et al. Mutational analysis of the RET proto-onocogene in 71 Japanese patients with medullary thyroid carcinoma. J Hum Genet 43:101–6, 1998. doi:10.1007/s100380050048.

    Article  PubMed  CAS  Google Scholar 

  22. Zhou Y, Zhao Y, Cui B, et al. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B. Clin Endocrinol 67:570–6, 2007.

    CAS  Google Scholar 

  23. Cook M, Molto EL, Anderson C. Possible case of hyperparathyroidism in a Roman period skeleton from the Dakhleh Oasis, Egypt, diagnosed using bone histomorpholometry. Am J Phys Anthrop 75:23–30, 1988. doi:10.1002/ajpa.1330750104.

    Article  PubMed  CAS  Google Scholar 

  24. Zink AR, Panzer S, Fesq-Martin M, et al. Evidence for a 7000-year-old case of primary hyperparathyroidism. JAMA 293:40–2, 2005. doi:10.1001/jama.293.1.40-c [Research Letter].

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are indebted to family members who generously gave their time and information. Dr. Leon Raskin, research fellow at the University of Michigan, provided technical assistance in genotyping. Dr. Gary Talpos, endocrine surgeon at Henry Ford Hospital in Detroit, MI, generously shared information about the family. The historical reviews of hyperparathyroidism by Dr. Norman Thompson [Acta Chir Scand 1990;156(1):5–21] and Dr. Claude H. Organ, Jr. [J Am Coll Surg 2000;191(3):284–299] enabled perspective and insight into the disorder.

The Institutional Review Board of the University of Michigan approved this investigation (UMCC 2-79).

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James C. Sisson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sisson, J.C., Giordano, T.J., Raymond, V.M. et al. First Description of Parathyroid Disease in Multiple Endocrine Neoplasia 2A Syndrome. Endocr Pathol 19, 289–293 (2008). https://doi.org/10.1007/s12022-008-9049-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-008-9049-8

Keywords

Navigation